Dos and Don’ts for Building Your Study in Castor
In this webinar, we discuss best and worst practices while building a study, when to use specific forms, working with fields effectively and tips to create a user-friendly study.
Castor Launches Scalable Decentralized Trial Platform After 383% Commercial Growth
Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…
Top Four eConsent Questions from Clinical Researchers
In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…
Castor Helps Power the WHO Solidarity Trial Against COVID-19
Castor Expands Advisory Board to Support US Growth of Decentralized Clinical Trial Platform
Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…
eBook: The Decentralized Clinical Trial Playbook
This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote interactions in their clinical studies.
UKCA Mark: The Impact of Brexit on Medical Devices and 7 Steps to Prepare
In the wake of Brexit, medical device companies secure a UKCA mark as proof of conformity to place their device on the UK market. Learn what this means for your organization and how to prepare.
Decentralized Trial Tech Strategy In Three Steps
Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has…
Guide: the electronic solution for patient reported outcome measures
Patient reported outcome measures in clinical trials have traditionally been done on paper. Surveys are a common way…